Tower Research Capital (TRC)’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Tower Research Capital (TRC)’s Portfolio KRBP Stock Details KRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,399	Closed	-$3.81K	–	6512
2023 Q2	$3.81K	Sell	1,399 -160	-10%	-$587	﹤0.01%	5021
2023 Q1	$6K	Buy	1,559 +1,403	+899%	+$7.42K	﹤0.01%	4922
2022 Q4	$1K	Sell	156 -6	-4%	-$48	﹤0.01%	5795
2022 Q3	$1K	Sell	162 -2	-1%	-$23	﹤0.01%	5948
2022 Q2	$2K	Buy	+164	New	+$2.59K	﹤0.01%	5674
2021 Q4	–	Sell	-27	Closed	-$2K	–	6841
2021 Q3	$2K	Buy	+27	New	+$2.79K	﹤0.01%	5358
2021 Q2	–	Sell	-2	Closed	–	–	6052
2021 Q1	$0	Sell	2 -199	-99%	-$58.3K	﹤0.01%	5877
2020 Q4	$51K	Buy	+201	New	+$57.1K	﹤0.01%	3116

Tower Research Capital (TRC)'s KRBP Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q3 2023, closing a stake of 1,399 shares — an estimated $3.81K sold.

Tower Research Capital (TRC) first reported a position in KRBP in Q4 2020 and held it in 8 quarters. The position peaked at $51K in Q4 2020. 0 funds tracked by Wall St. Rank hold KRBP as of Q3 2023.

Tower Research Capital (TRC) reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 1,399 Kiromic BioPharma, Inc. Common Stock shares in Q3 2023, an estimated $3.81K.
Tower Research Capital (TRC) first reported a position in Kiromic BioPharma, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Tower Research Capital (TRC)'s Kiromic BioPharma, Inc. Common Stock position peaked at $51K in Q4 2020.
0 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.